As at 27 October 2021, over 35 million doses of COVID-19 vaccines have been administered in Australia.
ATAGI has noted emerging national data demonstrating that only a small proportion of patients with severe COVID-19 were reported to be vaccinated, consistent with a high vaccine effectiveness against severe disease.
ATAGI reaffirms that the benefits of Comirnaty (Pfizer) and Spikevax (Moderna)outweigh the risks of myocarditis and/or pericarditis for any age group and strongly recommend eligible individuals without contraindications to be offered vaccination.
